Search research articles
Contact Us
Filters
Showing results (391-400 of 403) with videos related to
Page
of 41
Sort By:
Scientific Reports
|
December 29, 2019
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector
M Giel-Moloney, M Esteban, B H Oakes, et al.
Immunity
|
September 18, 2020
A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver
Lawrence T Wang, Lais S Pereira, Yevel Flores-Garcia, et al.
Nature Communications
|
March 23, 2024
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, et al.
Nature Communications
|
December 14, 2023
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, et al.
Nature Medicine
|
May 13, 2022
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial
Boris Julg, Kathryn E Stephenson, Kshitij Wagh, et al.
Cancer Discovery
|
April 21, 2026
Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II study
Salah-Eddine Bentebibel, Daniel J McGrail, Veena Kochat, et al.
Biorxiv : the Preprint Server for Biology
|
October 28, 2024
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV
Mohammad M Sajadi, Abdolrahim Abbasi, Zahra Rikhtegaran Tehrani, et al.
Mbio
|
September 9, 2025
Bayesian estimation of HIV acquisition dates for prevention trials
Raabya Rossenkhan, Elena E Giorgi, Danica Shao, et al.
The European Respiratory Journal
|
June 5, 2025
Multi-omic spatial profiling reveals the unique SARS-CoV-2 lung microenvironment and collagen VI as a predictive biomarker in severe COVID-19
Éanna Fennell, Graham S Taylor, Ciara I Leahy, et al.
Nature Medicine
|
August 22, 2022
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
Peter B Gilbert, Yunda Huang, Allan C deCamp, et al.
Page
of 41
Search research articles
Search
Showing results (391-400 of 403) with videos related to
Sort By:
Page
of 41
Scientific Reports
|
December 29, 2019
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector
M Giel-Moloney, M Esteban, B H Oakes, et al.
Immunity
|
September 18, 2020
A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the Liver
Lawrence T Wang, Lais S Pereira, Yevel Flores-Garcia, et al.
Nature Communications
|
March 23, 2024
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, et al.
Nature Communications
|
December 14, 2023
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
Daniel B Reeves, Bryan T Mayer, Allan C deCamp, et al.
Nature Medicine
|
May 13, 2022
Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial
Boris Julg, Kathryn E Stephenson, Kshitij Wagh, et al.
Cancer Discovery
|
April 21, 2026
Intratumoral sotigalimab with pembrolizumab induces rapid activation of antigen presenting cells and drives anti-tumor responses in non-injected tumors in metastatic melanoma: A phase I/II study
Salah-Eddine Bentebibel, Daniel J McGrail, Veena Kochat, et al.
Biorxiv : the Preprint Server for Biology
|
October 28, 2024
A comprehensive engineering strategy improves potency and manufacturability of a near pan-neutralizing antibody against HIV
Mohammad M Sajadi, Abdolrahim Abbasi, Zahra Rikhtegaran Tehrani, et al.
Mbio
|
September 9, 2025
Bayesian estimation of HIV acquisition dates for prevention trials
Raabya Rossenkhan, Elena E Giorgi, Danica Shao, et al.
The European Respiratory Journal
|
June 5, 2025
Multi-omic spatial profiling reveals the unique SARS-CoV-2 lung microenvironment and collagen VI as a predictive biomarker in severe COVID-19
Éanna Fennell, Graham S Taylor, Ciara I Leahy, et al.
Nature Medicine
|
August 22, 2022
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
Peter B Gilbert, Yunda Huang, Allan C deCamp, et al.
Page
of 41